基本信息
views: 463
Career Trajectory
Bio
Dr. Matin has an active clinical practice focusing on the entire spectrum of care for renal cell carcinoma (RCC) and upper urinary tract urothelial cancer (UTUC), ranging from surveillance, endoscopic, laparoscopic, robotic, open and salvage operations for localized and metastatic disease, as well as minimally invasive treatment of adrenal tumors. Dr. Matin has one of the largest UTUC practices in the country. His primary research efforts are based on genomic characterization of UTUC and multiple other lines of research seeking to shed light on this rare cancer, along with clinical research in UTUC and RCC. He actively collaborates with other clinicians, pathologists, radiologists, translational scientists and basic scientists as can be seen in his selected publications.
Research Interests
Papers共 625 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Urologic Oncology: Seminars and Original Investigations (2024)
Jennifer Linehan,Josh Gottlieb,Solomon L. Woldu, Craig Labbatec,Kyle Rose, Wade Sextond, Hristos Kaimakliotise, Joseph Jacobf, Rian Dicksteing, Alan Niederi, Marc Bjurlinj, Mitchell Humphreysk,
EUROPEAN UROLOGY FOCUSno. 1 (2024): 212-212
The Journal of urologyno. 6 (2024): 784-793
Urologic Oncology: Seminars and Original Investigations (2024)
EUROPEAN UROLOGY ONCOLOGYno. 2 (2024): 266-274
EUROPEAN RADIOLOGY (2024)
Journal of Vascular and Interventional Radiologyno. 3 (2024): S105-S106
Urologic Oncology: Seminars and Original Investigations (2024)
Load More
Author Statistics
#Papers: 629
#Citation: 19379
H-Index: 69
G-Index: 128
Sociability: 8
Diversity: 3
Activity: 91
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn